Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Follo

Showing results (61-70 of 150) with videos related to

Pageof 15
Sort By:
Journal of Patient Experience|April 11, 2022
Sustained Improvement in Patient Experience by Optimizing Patient Flow in Ambulatory SettingsDinesh S Pashankar, Troy Brown, Paul Votto, et al.
Oncotarget|April 19, 2017
Proteasome inhibition enhances the efficacy of volasertib-induced mitotic arrest in AML in vitro and prolongs survival in vivoDominik Schnerch, Julia Schüler, Marie Follo, et al.
American Journal of Cancer Research|August 6, 2021
Targeting mitotic exit in solid tumorsChristine Greil, Julia Felthaus, Marie Follo, et al.
British Journal of Haematology|February 7, 2013
Potent in vitro and in vivo activity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerizationJosefina Udi, Julia Schüler, Dagmar Wider, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 2, 2010
Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantationSilvia Rathmann, Sabine Glatzel, Kathrin Schönberg, et al.
Haematologica|October 15, 2020
Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myelomaSandra Maria Dold, Veronika Riebl, Dagmar Wider, et al.
Cellular Immunology|June 15, 2012
Rap1a deficiency modifies cytokine responses and MAPK-signaling in vitro and impairs the in vivo inflammatory responseAnnette Dorn, Anna Zoellner, Marie Follo, et al.
International Journal of Legal Medicine|October 9, 2007
Single lymphocytes from two healthy individuals with mitochondrial point heteroplasmy are mainly homoplasmicSabine Lutz-Bonengel, Timo Sänger, Walther Parson, et al.
Experimental and Molecular Pathology|May 21, 2014
Detection of MYD88 L265P mutations in formalin-fixed and decalcified BM biopsies from patients with lymphoplasmacytic lymphomaIanina Belén Capaldi, Annette M May, Annette Schmitt-Graeff, et al.
Plos One|December 29, 2010
Non-invasive in vivo imaging of tumor-associated CD133/promininChizuko Tsurumi, Norbert Esser, Elke Firat, et al.
Pageof 15

Showing results (61-70 of 150) with videos related to

Sort By:
Pageof 15
Journal of Patient Experience|April 11, 2022
Sustained Improvement in Patient Experience by Optimizing Patient Flow in Ambulatory SettingsDinesh S Pashankar, Troy Brown, Paul Votto, et al.
Oncotarget|April 19, 2017
Proteasome inhibition enhances the efficacy of volasertib-induced mitotic arrest in AML in vitro and prolongs survival in vivoDominik Schnerch, Julia Schüler, Marie Follo, et al.
American Journal of Cancer Research|August 6, 2021
Targeting mitotic exit in solid tumorsChristine Greil, Julia Felthaus, Marie Follo, et al.
British Journal of Haematology|February 7, 2013
Potent in vitro and in vivo activity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerizationJosefina Udi, Julia Schüler, Dagmar Wider, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 2, 2010
Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantationSilvia Rathmann, Sabine Glatzel, Kathrin Schönberg, et al.
Haematologica|October 15, 2020
Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myelomaSandra Maria Dold, Veronika Riebl, Dagmar Wider, et al.
Cellular Immunology|June 15, 2012
Rap1a deficiency modifies cytokine responses and MAPK-signaling in vitro and impairs the in vivo inflammatory responseAnnette Dorn, Anna Zoellner, Marie Follo, et al.
International Journal of Legal Medicine|October 9, 2007
Single lymphocytes from two healthy individuals with mitochondrial point heteroplasmy are mainly homoplasmicSabine Lutz-Bonengel, Timo Sänger, Walther Parson, et al.
Experimental and Molecular Pathology|May 21, 2014
Detection of MYD88 L265P mutations in formalin-fixed and decalcified BM biopsies from patients with lymphoplasmacytic lymphomaIanina Belén Capaldi, Annette M May, Annette Schmitt-Graeff, et al.
Plos One|December 29, 2010
Non-invasive in vivo imaging of tumor-associated CD133/promininChizuko Tsurumi, Norbert Esser, Elke Firat, et al.
Pageof 15